Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets

v3.22.2
Condensed Consolidated Balance Sheets - USD ($)
Jun. 30, 2022
Dec. 31, 2021
CURRENT ASSETS    
Cash $ 429,353 $ 1,499,866
Prepaid expenses and other current assets 108,221 135,014
Deferred offering costs 35,000
TOTAL CURRENT ASSETS 537,574 1,669,880
TOTAL ASSETS 537,574 1,669,880
CURRENT LIABILITIES    
Accounts payable and accrued expenses 994,464 569,321
Accrued payroll and related expenses 588,805 95,400
Accrued Series B preferred stock dividends 228,584 153,343
Convertible notes payable, net of discount 550,550 532,400
Notes payable - related parties 7,500 7,500
Debentures 35,000
TOTAL CURRENT LIABILITIES 2,369,903 1,392,964
TOTAL LIABILITIES 2,369,903 1,392,964
Redeemable convertible preferred stock - Series A; $0.0001 par value, 1,500 designated Series A, and 480 shares issued and outstanding (liquidation preference of $706,800 and $693,580) as of June 30, 2022 and December 31, 2021 706,800 693,580
STOCKHOLDERS’ DEFICIT    
Common stock, $0.0001 par value, 300,000,000 shares authorized, 1,686,587 and 1,652,102 shares issued and outstanding as of June 30, 2022 and December 31, 2021, respectively 169 165
Unearned deferred compensation (472,292) (900,742)
Additional paid-in capital 30,327,583 29,765,585
Accumulated deficit (32,394,591) (29,281,674)
TOTAL STOCKHOLDERS’ DEFICIT (2,539,129) (416,664)
TOTAL LIABILITIES AND STOCKHOLDERS’ DEFICIT 537,574 1,669,880
Series B Preferred Stock [Member]    
STOCKHOLDERS’ DEFICIT    
Preferred stock, value 2 2
Series E-1 Preferred Stock [Member]    
STOCKHOLDERS’ DEFICIT    
Preferred stock, value